[e-drug] Independent Evaluation of the AMFm Pilot Phase in Global Fund

E-DRUG: Independent Evaluation of the AMFm Pilot Phase in Global Fund
---------------------------------------------------------------------

Global Fund Announcement:

RELEASE OF THE FINAL REPORT OF THE INDEPENDENT EVALUATION OF THE AMFM PILOT PHASE

The Global Fund to Fight AIDS, Tuberculosis and Malaria released the final report on the Independent Evaluation of the Affordable Medicines Facility - malaria (AMFm) pilot phase.

As host and manager of the AMFm, the Global Fund commissioned an independent evaluation to assess the extent to which the initiative has achieved the main objectives laid out for its pilot phase, which ends in December 2012.

The Independent Evaluation, a thorough assessment of the initiative, was mandated by the Global Fund Board and will inform its discussions in November 2012, when the Board is expected to make a decision on the future of AMFm beyond the pilot phase.

The full report is available here: http://www.theglobalfund.org/en/amfm/independentevaluation/

regards

Silas Holland
Specialist, Operations and Coordination
Affordable Medicines Facility-malaria (AMFm)
The Global Fund to Fight AIDS, Tuberculosis and Malaria Chemin de Blandonnet 8 | 1214 Vernier-Geneva, Switzerland
T: +41 58 791 1637 | F: +41 58 791 1701 Silas.Holland@TheGlobalFund.org www.theglobalfund.org